Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Hims & Hers Stock Crashed on Tuesday

TheMotleyFool

0 0

Why Hims & Hers Stock Crashed on Tuesday: https://g.foolcdn.com/editorial/images/788749/pills-dollar-sign-money-pharmaceuticals.jpg

Shares of Hims & Hers (NYSE: HIMS) fell as much as 8% on Tuesday and closed at their low for the day after news broke that Eli Lilly (NYSE: LLY) lowered the price for a key weight loss drug.

The big news on Tuesday was an announcement that Eli Lilly will sell the weight loss drug Zepbound through its direct-to-consumer website at a 50% discount to the previous price. A 2.5 milligram single-dose vial will cost $399 for a month's supply, while a 5 milligram dose will be $549 per month.

This is the first name-brand GLP-1 weight loss treatment to be this inexpensive without using the shortage exemption Hims & Hers uses to sell a compounded version of the drugs. Today, investors think that's a threat to a key growth avenue for the company.

Source Fool.com

Like: 0

HIMS

Share